No Data
No Data
Analysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), Revelation Biosciences (REVB)
Why Investors Shouldn't Be Surprised By Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) 27% Share Price Plunge
Industry Analysts Just Made A Captivating Upgrade To Their Mersana Therapeutics, Inc. (NASDAQ:MRSN) Revenue Forecasts
Leerink Partners Maintains Mersana Therapeutics(MRSN.US) With Buy Rating, Maintains Target Price $5
Truist Financial Maintains Mersana Therapeutics(MRSN.US) With Buy Rating
Mersana Therapeutics Full Year 2024 Earnings: Beats Expectations